Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of HCP0910 and HGP1011 Co-administration
NCT02441114Phase 1Completed
- Sponsor
- Seoul National University Hospital
- Start
- Jul 2015
- Primary completion
- Oct 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of fluticasone propionate nasal spray, salmeterol and tiotropium in chronic obstructive pulmonary disease (COPD), sponsored by Seoul National University Hospital. Primary endpoint: Area Under the Concentration Versus Time Curve. Started Jul 2015; status: completed.
02
Drugs
fluticasone propionate nasal spraysalmeteroltiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02441114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02441114.